Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $5.76 | Prev. Close $5.74 | Circuit Range N/A |
Day Range $5.58 - $5.84 | Year Range $0.91 - $16.34 | Volume 2,453 |
Average Traded $5.71 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $5.76 | $5.87 | +0.00% |
04-Dec-25 | $5.76 | $5.87 | +9.72% |
02-Dec-25 | $6.23 | $5.35 | -20.21% |
01-Dec-25 | $7.08 | $6.71 | -7.33% |
26-Nov-25 | $7.33 | $7.24 | +0.91% |
25-Nov-25 | $7.18 | $7.17 | +3.46% |
24-Nov-25 | $6.92 | $6.93 | -0.14% |